603222 济民健康
已收盘 04-17 15:00:00
资讯
新帖
简况
每周股票复盘：济民健康（603222）股价异动登龙虎榜
证券之星 · 04-12
每周股票复盘：济民健康（603222）股价异动登龙虎榜
济民健康(603222.SH)子公司DB006溶瘤腺病毒注射液获得药物临床试验批准通知书
智通财经 · 04-08
济民健康(603222.SH)子公司DB006溶瘤腺病毒注射液获得药物临床试验批准通知书
4月7日济民健康（603222）龙虎榜数据
证券之星 · 04-07
4月7日济民健康（603222）龙虎榜数据
济民健康最新公告：控股股东拟7.72元/股的价格协议转让5%公司股份
证券之星 · 04-07
济民健康最新公告：控股股东拟7.72元/股的价格协议转让5%公司股份
济民健康（603222）披露2026年第一次临时股东会决议公告，4月3日股价上涨3.15%
证券之星 · 04-03
济民健康（603222）披露2026年第一次临时股东会决议公告，4月3日股价上涨3.15%
BD+业绩双重炸裂，创新药多股涨停，黄金窗口期来了？
格隆汇 · 04-02
BD+业绩双重炸裂，创新药多股涨停，黄金窗口期来了？
医药、医疗产业链持续走强 济民健康等多股涨停
每日经济新闻 · 04-02
医药、医疗产业链持续走强 济民健康等多股涨停
每周股票复盘：济民健康（603222）拟引入战投增资鄂州二医院
证券之星 · 03-29
每周股票复盘：济民健康（603222）拟引入战投增资鄂州二医院
济民健康（603222）披露子公司鄂州二医院引入战略投资者公告，3月26日股价下跌1.01%
证券之星 · 03-26
济民健康（603222）披露子公司鄂州二医院引入战略投资者公告，3月26日股价下跌1.01%
每周股票复盘：济民健康（603222）子公司增资引入战投获首付款
证券之星 · 03-22
每周股票复盘：济民健康（603222）子公司增资引入战投获首付款
济民健康(603222.SH)：已累计回购2.22%公司股份
中金财经 · 03-19
济民健康(603222.SH)：已累计回购2.22%公司股份
济民健康（603222）披露关于子公司增资扩股引入战略投资者暨关联交易的议案，3月17日股价下跌1.01%
证券之星 · 03-17
济民健康（603222）披露关于子公司增资扩股引入战略投资者暨关联交易的议案，3月17日股价下跌1.01%
济民健康(603222.SH)：长河军民创新拟以1.83亿元向鄂州二院增资 公司放弃本次增资的优先认缴权
中金财经 · 03-17
济民健康(603222.SH)：长河军民创新拟以1.83亿元向鄂州二院增资 公司放弃本次增资的优先认缴权
济民健康（603222）披露5%股份协议转让事项，3月9日股价上涨2.47%
证券之星 · 03-09
济民健康（603222）披露5%股份协议转让事项，3月9日股价上涨2.47%
每周股票复盘：济民健康（603222）股东协议转让5%股份
证券之星 · 03-08
每周股票复盘：济民健康（603222）股东协议转让5%股份
济民健康(603222.SH)：控股股东拟协议转让5%股份
中金财经 · 03-06
济民健康(603222.SH)：控股股东拟协议转让5%股份
济民健康（603222）披露回购公司股份比例达2%暨回购进展公告，2月27日股价上涨4.0%
证券之星 · 02-27
济民健康（603222）披露回购公司股份比例达2%暨回购进展公告，2月27日股价上涨4.0%
每周股票复盘：济民健康（603222）回购股份达1.02%
证券之星 · 02-01
每周股票复盘：济民健康（603222）回购股份达1.02%
济民健康（603222）披露回购公司股份比例达1%暨回购进展公告，1月30日股价下跌0.71%
证券之星 · 01-30
济民健康（603222）披露回购公司股份比例达1%暨回购进展公告，1月30日股价下跌0.71%
济民健康2025年净利预亏2.1亿元至2.5亿元，同比增亏
滚动播报 · 01-23
济民健康2025年净利预亏2.1亿元至2.5亿元，同比增亏
公司概况
公司名称：
济民健康管理股份有限公司
所属行业：
医药制造业
上市日期：
2015-02-17
主营业务：
济民健康管理股份有限公司的主营业务是医疗服务业务，医疗器械的研发、生产和销售，大输液系列产品的研发、生产和销售。公司的主要产品是医疗服务、注射穿刺器械系列产品、预充式导管冲洗器系列产品、体外诊断系列产品、基础输液、电解质输液、冲洗剂、治疗性输液。
发行价格：
7.36
{"stockData":{"symbol":"603222","market":"SH","secType":"STK","nameCN":"济民健康","latestPrice":10.54,"timestamp":1776409201000,"preClose":10.62,"halted":0,"volume":33126554,"delay":0,"changeRate":-0.0075,"floatShares":525000000,"shares":525000000,"eps":-0.3148,"marketStatus":"已收盘","change":-0.08,"latestTime":"04-17 15:00:00","open":10.61,"high":10.65,"low":10.32,"amount":347000000,"amplitude":0.0311,"askPrice":10.54,"askSize":946,"bidPrice":10.53,"bidSize":135,"shortable":0,"etf":0,"ttmEps":-0.3148,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776648600000},"marketStatusCode":5,"adr":0,"adjPreClose":10.62,"symbolType":"stock","openAndCloseTimeList":[[1776389400000,1776396600000],[1776402000000,1776409200000]],"highLimit":11.68,"lowLimit":9.56,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":525090615,"isCdr":false,"pbRate":3.96,"roa":"--","roe":"--","epsLYR":-0.11,"committee":-0.719615,"marketValue":5534000000,"turnoverRate":0.0631,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-04-20。","floatMarketCap":5534000000},"requestUrl":"/m/hq/s/603222/wiki","defaultTab":"wiki","newsList":[{"id":"2626124769","title":"每周股票复盘：济民健康（603222）股价异动登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2626124769","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626124769?lang=zh_cn&edition=full","pubTime":"2026-04-12 01:26","pubTimestamp":1775928370,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘，济民健康报收于10.21元，较上周的10.47元下跌2.48%。本周，济民健康4月7日盘中最高价报11.52元。本周关注点来自交易信息汇总：济民健康因三日涨幅偏离值超20%登上龙虎榜。济民健康管理股份有限公司关于股票交易异常波动的公告济民健康股票于2026年4月2日、4月3日、4月7日连续三个交易日内收盘价格涨幅偏离值累计超过20%，构成交易异常波动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603222","BK0201","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625160329","title":"济民健康(603222.SH)子公司DB006溶瘤腺病毒注射液获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2625160329","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625160329?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:14","pubTimestamp":1775636061,"startTime":"0","endTime":"0","summary":"智通财经APP讯，济民健康(603222.SH)发布公告，近日，公司控股子公司海南济民博鳌国际医院有限公司(简称“博鳌国际医院”)收到国家药品监督管理局核准签发的关于博鳌国际医院的“DB006溶瘤腺病毒注射液”的《药物临床试验批准通知书》，同意开展末线恶性实体肿瘤的临床试验。博鳌国际医院DB006溶瘤腺病毒注射液是一款用于治疗晚期恶性实体肿瘤的基因治疗药物，该产品利用基因工程的方法，对溶瘤病毒进行了多个方面的改造，以实现选择性感染肿瘤细胞、增强病毒的肿瘤特异性复制能力;同时，该产品通过多个抗肿瘤及免疫调节基因的导入，利用多个靶点杀伤肿瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"济民健康(603222.SH)子公司DB006溶瘤腺病毒注射液获得药物临床试验批准通知书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","603222","BK0251","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625936489","title":"4月7日济民健康（603222）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2625936489","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625936489?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:15","pubTimestamp":1775553306,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年4月7日公布的交易公开信息显示，济民健康因非ST、*ST和S证券连续三个交易日内收盘价格涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年4月7日收盘，济民健康报收于11.27元，上涨7.64%，换手率18.27%，成交量95.91万手，成交额10.44亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603222","BK0201","BK0251","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625893660","title":"济民健康最新公告：控股股东拟7.72元/股的价格协议转让5%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2625893660","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625893660?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:09","pubTimestamp":1775552991,"startTime":"0","endTime":"0","summary":"济民健康(603222.SH)发布异动公告，公司控股股东双鸽集团于2026年3月6日与湖北长河壹号科技合伙企业（有限合伙）签订了股份转让协议，拟通过协议转让的方式，双鸽集团向长河壹号转让其所持有济民健康无限售流通股26,254,600股股份，占济民健康总股本的5%，转让价格为7.72元/股。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700023841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","603222","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624682576","title":"济民健康（603222）披露2026年第一次临时股东会决议公告，4月3日股价上涨3.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624682576","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624682576?lang=zh_cn&edition=full","pubTime":"2026-04-03 22:04","pubTimestamp":1775225062,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，济民健康报收于10.47元，较前一交易日上涨3.15%，最新总市值为54.98亿元。该股当日开盘10.24元，最高11.0元，最低9.85元，成交额达10.54亿元，换手率为19.39%。公司于近日披露《济民健康管理股份有限公司2026年第一次临时股东会决议公告》。公告显示，济民健康于2026年4月2日召开2026年第一次临时股东会，会议由董事会召集，董事长徐赞主持，采用现场与网络投票结合方式召开。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300043102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603222","BK0201","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624157850","title":"BD+业绩双重炸裂，创新药多股涨停，黄金窗口期来了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2624157850","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624157850?lang=zh_cn&edition=full","pubTime":"2026-04-02 14:03","pubTimestamp":1775109822,"startTime":"0","endTime":"0","summary":"进入收获期","market":"fut","thumbnail":"https://img3.gelonghui.com/a401d-e32ea773-2592-402d-a56d-8ff49dc1dd78.jpg?guru_height=718&guru_width=1280&guru_size=112216","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a401d-e32ea773-2592-402d-a56d-8ff49dc1dd78.jpg?guru_height=718&guru_width=1280&guru_size=112216"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4283048","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["SGCmain","IAU","BK0188","PHYS","603222","159934","600488","USG","XME","300086","06978","SGOL","1OZmain","GLL","QOmain","159831","02162","NUGT","GLTR","DUST","SGUmain","AAAU","UGL","GDX","GDXJ","000788","PALL","BTGD","GLDM","CEF","518880","GDXU","OUNZ","GCmain","BK4585","BK1191","600594","000950","02186","GLD","JNUG","IAUI","GDXY","DGP","GDXD","DZZ","IAUM","JDST","159992","MGCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624520491","title":"医药、医疗产业链持续走强 济民健康等多股涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2624520491","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624520491?lang=zh_cn&edition=full","pubTime":"2026-04-02 13:42","pubTimestamp":1775108520,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月2日，午后医药产业链持续走强，医药商业等细分展开补涨，济民健康、合富中国涨停，此前津药药业、益佰制药、北大医药涨停，华人健康、百洋医药、漱玉平民、建发致新、人民同泰等多股涨超5%。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-04-02/doc-inhtavkf9449505.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-02/doc-inhtavkf9449505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK0239","BK1574","603222","BK0201","159938","159891","09939","BK0251","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623333823","title":"每周股票复盘：济民健康（603222）拟引入战投增资鄂州二医院","url":"https://stock-news.laohu8.com/highlight/detail?id=2623333823","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623333823?lang=zh_cn&edition=full","pubTime":"2026-03-29 04:07","pubTimestamp":1774728429,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，济民健康报收于8.97元，较上周的8.69元上涨3.22%。本周，济民健康3月23日盘中最高价报9.07元。济民健康当前最新总市值47.1亿元，在医疗器械板块市值排名76/129，在两市A股市值排名3519/5191。本周关注点公司公告汇总：济民健康拟通过子公司鄂州二医院增资扩股引入战略投资者，长河军民创新以现金18,260.60万元增资，持股40%。董事会已审议通过该事项，现提请股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0239","603222","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622869613","title":"济民健康（603222）披露子公司鄂州二医院引入战略投资者公告，3月26日股价下跌1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622869613","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622869613?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:35","pubTimestamp":1774535717,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘，济民健康报收于8.82元，较前一交易日下跌1.01%，最新总市值为46.31亿元。近日，济民健康管理股份有限公司披露《2026年第一次临时股东会会议材料》。公告显示，公司拟通过子公司鄂州二医院有限公司增资扩股引入战略投资者湖北长河军民创新医疗科技有限公司。长河军民创新将以现金18,260.60万元增资，投前估值为27,398.14万元，增资后持有鄂州二院40%股权，济民健康仍持股60%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600044702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0251","BK0239","603222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621796003","title":"每周股票复盘：济民健康（603222）子公司增资引入战投获首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2621796003","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621796003?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:28","pubTimestamp":1774117691,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，济民健康报收于8.69元，较上周的8.84元下跌1.7%。本周，济民健康3月18日盘中最高价报9.28元。本周关注点来自公司公告汇总：子公司鄂州二医院引入战略投资者，已收到首期投资款1,826.06万元。独立董事已对关联交易事项进行事前审核。股本股东变化济民健康于2025年3月28日启动股份回购计划，截至2026年3月18日，累计回购股份11,645,140股，占公司总股本2.22%，实际回购金额100,079,055元，回购价格区间为5.87元/股至9.75元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0201","603222","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620989249","title":"济民健康(603222.SH)：已累计回购2.22%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2620989249","media":"中金财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620989249?lang=zh_cn&edition=full","pubTime":"2026-03-19 18:17","pubTimestamp":1773915423,"startTime":"0","endTime":"0","summary":"格隆汇3月19日丨济民健康(603222.SH)公布，截至2026年3月18日，公司本次股份回购计划实施完毕。公司通过上海证券交易所交易系统以集中竞价交易方式已累计回购公司股份数量为1164.51万股，占公司总股本的比例为2.22%，回购成交的最高价为9.75元/股，最低价为5.87元/股，累计支付的资金总额为人民币1亿元(不含交易费用)，目前全部存放于公司股份回购专用证券账户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260319/32081881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK0251","603222","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620147541","title":"济民健康（603222）披露关于子公司增资扩股引入战略投资者暨关联交易的议案，3月17日股价下跌1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620147541","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620147541?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:49","pubTimestamp":1773758952,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘，济民健康报收于8.82元，较前一交易日下跌1.01%，最新总市值为46.31亿元。近日，济民健康管理股份有限公司发布《关于召开2026年第一次临时股东会的通知》，宣布将于2026年4月2日召开2026年第一次临时股东会。会议将审议《关于子公司增资扩股引入战略投资者暨关联交易的议案》《公司未来三年股东回报规划》《关于修订〈董事、高级管理人员薪酬管理制度〉的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603222","BK0201","BK0251","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620400934","title":"济民健康(603222.SH)：长河军民创新拟以1.83亿元向鄂州二院增资 公司放弃本次增资的优先认缴权","url":"https://stock-news.laohu8.com/highlight/detail?id=2620400934","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620400934?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:27","pubTimestamp":1773739626,"startTime":"0","endTime":"0","summary":"格隆汇3月17日丨济民健康(603222.SH)公布，公司全资子公司鄂州二医院有限公司(以下简称“鄂州二院”或“目标公司”)拟引入战略投资者湖北长河军民创新医疗科技有限公司(以下简称“长河军民创新”或“增资方”)。增资方拟按照27,398.14万元的投前估值，以现金18,260.60万元向鄂州二院增资，增资完成后长河军民创新持有鄂州二院40%股权，公司持有鄂州二院60%股权。\r\n\r\n 公司放弃本次增资的优先认缴权，待投资者本次增资完成后，公司仍持有鄂州二院60%的股份，鄂州二院仍然为公司的控股子公司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260317/32075068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603222","BK0251","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618622061","title":"济民健康（603222）披露5%股份协议转让事项，3月9日股价上涨2.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618622061","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618622061?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:41","pubTimestamp":1773067279,"startTime":"0","endTime":"0","summary":"截至2026年3月9日收盘，济民健康报收于9.11元，较前一交易日上涨2.47%，最新总市值为47.84亿元。该股当日开盘9.0元，最高9.3元，最低8.97元，成交额达1.42亿元，换手率为2.96%。近日，济民健康管理股份有限公司披露《简式权益变动报告书（受让方）》。本次权益变动后，长河壹号持有上市公司5%股份，资金来源为自有或自筹资金。长河壹号承诺12个月内不转让所持股份。本次变动不导致公司控股股东、实际控制人变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900035509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0251","BK0239","603222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617663326","title":"每周股票复盘：济民健康（603222）股东协议转让5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663326","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663326?lang=zh_cn&edition=full","pubTime":"2026-03-08 02:54","pubTimestamp":1772909650,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，济民健康报收于8.89元，较上周的9.36元下跌5.02%。本周，济民健康3月2日盘中最高价报9.28元。济民健康当前最新总市值46.68亿元，在医疗器械板块市值排名79/129，在两市A股市值排名3710/5190。本周关注点公司公告汇总：控股股东拟协议转让5%股份，受让方承诺12个月不减持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603222","BK0251","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617687319","title":"济民健康(603222.SH)：控股股东拟协议转让5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2617687319","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617687319?lang=zh_cn&edition=full","pubTime":"2026-03-06 19:47","pubTimestamp":1772797626,"startTime":"0","endTime":"0","summary":"格隆汇3月6日丨济民健康(603222.SH)公布，控股股东双鸽集团有限公司(简称“双鸽集团”)于2026年3月6日与湖北长河壹号科技合伙企业(有限合伙)(简称“长河壹号”)签订了《关于济民健康管理股份有限公司之股份转让协议》，通过协议转让的方式，向长河壹号转让其所持有济民健康无限售流通股2625.46万股股份，占济民健康总股本的5%，转让价格为7.72元/股，转让对价2.03亿元人民币。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260306/32050676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603222","BK0201","BK0251","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614854995","title":"济民健康（603222）披露回购公司股份比例达2%暨回购进展公告，2月27日股价上涨4.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614854995","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614854995?lang=zh_cn&edition=full","pubTime":"2026-02-27 22:23","pubTimestamp":1772202195,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，济民健康报收于9.36元，较前一交易日上涨4.0%，最新总市值为49.15亿元。近日，济民健康管理股份有限公司发布《关于回购公司股份比例达2%暨回购进展公告》。截至2026年2月27日，公司累计回购股份10,626,840股，占总股本的2.02%，已支付总金额90,962,358.7元，回购价格区间为5.87元/股至9.75元/股。2026年2月单月回购5,286,560股，占总股本1.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700042353.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","603222","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608077524","title":"每周股票复盘：济民健康（603222）回购股份达1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608077524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608077524?lang=zh_cn&edition=full","pubTime":"2026-02-01 02:46","pubTimestamp":1769885171,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，济民健康报收于8.4元，较上周的9.45元下跌11.11%。本周，济民健康1月26日盘中最高价报9.35元。本周关注点公司公告汇总：济民健康回购股份达总股本1.02%，支付金额超4208万元。济民健康管理股份有限公司于2025年3月28日召开董事会，审议通过以集中竞价交易方式回购股份的方案，回购价格不超10元/股，资金总额10,000万元至20,000万元，期限为董事会审议通过后12个月内。2026年1月单月回购2,279,780股，占总股本0.43%，支付金额20,101,754.8元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603222","BK0251","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607849044","title":"济民健康（603222）披露回购公司股份比例达1%暨回购进展公告，1月30日股价下跌0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607849044","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607849044?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:50","pubTimestamp":1769784628,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，济民健康报收于8.4元，较前一交易日下跌0.71%，最新总市值为44.11亿元。近日，济民健康管理股份有限公司发布《关于回购公司股份比例达1%暨回购进展公告》。截至2026年1月30日，公司累计回购股份5,340,280股，占总股本的1.02%，已支付金额42,085,552.3元，回购最高价9.75元/股，最低价5.87元/股。2026年1月单月回购2,279,780股，占总股本0.43%，支付金额20,101,754.8元。上述进展符合相关规定，公司将继续推进回购并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000047696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","603222","BK0251","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605403081","title":"济民健康2025年净利预亏2.1亿元至2.5亿元，同比增亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2605403081","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605403081?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:04","pubTimestamp":1769177040,"startTime":"0","endTime":"0","summary":"（来源：北京商报）北京商报讯（记者 丁宁）1月23日晚间，济民健康（603222）发布2025年年度业绩预亏公告显示，公司预计2025年度归属净利润为-2.1亿元至-2.5亿元，与上年同期相比，将增加亏损。济民健康表示，报告期内，受“何清红私刻印章事件”等因素的影响，公司收入进一步下滑，导致公司亏损进一步增加。另外，公告显示，本期业绩预亏还受计提存货跌价准备，确认涉案经销商相关损失，计提鄂州二医院商誉减值准备等因素的影响。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-01-23/doc-inhiiips0786334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603222","BK0251","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1776461298728,"stockEarnings":[{"period":"1week","weight":0.0323},{"period":"1month","weight":0.1544},{"period":"3month","weight":0.1309},{"period":"6month","weight":0.0067},{"period":"1year","weight":0.7655},{"period":"ytd","weight":0.1544}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":-0.0028},{"period":"3month","weight":-0.0123},{"period":"6month","weight":0.0551},{"period":"1year","weight":0.2351},{"period":"ytd","weight":0.0208}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"济民健康管理股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"58116人(较上一季度增加107.00%)","perCapita":"9035股","listingDate":"2015-02-17","address":"浙江省台州市黄岩区北院路888号","registeredCapital":"52509万元","survey":" 济民健康管理股份有限公司的主营业务是医疗服务业务，医疗器械的研发、生产和销售，大输液系列产品的研发、生产和销售。公司的主要产品是医疗服务、注射穿刺器械系列产品、预充式导管冲洗器系列产品、体外诊断系列产品、基础输液、电解质输液、冲洗剂、治疗性输液。","listedPrice":7.36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"济民健康(603222)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供济民健康(603222)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"济民健康,603222,济民健康股票,济民健康股票老虎,济民健康股票老虎国际,济民健康行情,济民健康股票行情,济民健康股价,济民健康股市,济民健康股票价格,济民健康股票交易,济民健康股票购买,济民健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"济民健康(603222)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供济民健康(603222)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}